Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy

Journal of Experimental Medicine

Volumn 214, Issue 4, 2017, Pages 943-957

  Diny, Nicola L ^a   Baldeviano, G Christian ^b,c   Talor, Monica V ^b   Barin, Jobert G ^b   Ong, SuFey ^a,d   Bedja, Djahida ^b   Hays, Allison G ^b   Gilotra, Nisha A ^b   Coppens, Isabelle ^a   Rose, Noel R ^a,b,e   Čiháková, Daniela ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Virology Program   (Peru)

^d BENAROYA RESEARCH INSTITUTE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN F; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EOSINOPHIL; EOSINOPHILIC MYOCARDITIS; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; GENE DELETION; HEART ATRIUM; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE; HUMAN; HUMAN CELL; INFLAMMATORY DILATED CARDIOMYOPATHY; MOUSE; MYOCARDITIS; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; CARDIOMYOPATHY, DILATED; COMPLICATION; FIBROSIS; PHYSIOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; CARDIOMYOPATHY, DILATED; DISEASE PROGRESSION; EOSINOPHILS; FIBROSIS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; MYOCARDITIS;

EID: 85018455334     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20161702     Document Type: Article

References (95)

1. Ahmad, I., D. Craig Miller, G.J. Berry, H.H. Hsia, P.J. Wang, and A. Al-Ahmad. 2006. Isolated giant cell myocarditis in the atrium: an incidental finding? Pacing Clin. Electrophysiol. 29:1179-1180. http ://dx .doi .org/10 .1111/j .1540-8159 .2006 .00512 .x
2. Aretz, H.T., M.E. Billingham, W.D. Edwards, S.M. Factor, J.T. Fallon, J.J. Fenoglio Jr., E.G. Olsen, and F.J. Schoen. 1987. Myocarditis. A histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1:3-14
3. Baandrup, U. 2012. Eosinophilic myocarditis. Herz. 37:849-853. http ://dx .doi .org/10 .1007/s00059-012-3701-2
4. Baldeviano, G.C., J.G. Barin, M.V. Talor, S. Srinivasan, D. Bedja, D. Zheng, K. Gabrielson, Y. Iwakura, N.R. Rose, and D. Ciháková. 2010. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ. Res. 106:1646-1655. http ://dx .doi .org/10 .1161/CIR CRE SAHA .109 .213157
5. Barin, J.G., G.C. Baldeviano, M.V. Talor, L. Wu, S. Ong, D. Fairweather, D. Bedja, N.R. Stickel, J.A. Fontes, A.B. Cardamone, et al. 2013. Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A. J. Immunol. 191:4038-4047. http ://dx .doi .org/10 .4049/jimmunol .1301282
6. Bochner, B.S., W. Book, W.W. Busse, J. Butterfield, G.T. Furuta, G.J. Gleich, A.D. Klion, J.J. Lee, K.M. Leiferman, M. Minnicozzi, et al. 2012. Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TRE AD). J. Allergy Clin. Immunol. 130:587-596. http ://dx .doi .org/10 .1016/j .jaci .2012 .07 .024
7. Carver, J.R., S. Nasta, E.A. Chong, M. Stonecypher, J.E. Wheeler, T. Ahmadi, and S.J. Schuster. 2010. Myocarditis during lenalidomide therapy. Ann. Pharmacother. 44:1840-1843. http ://dx .doi .org/10 .1345/aph .1P044
8. Chisty, M.M., M. Nargis, H. Sato, T. Inaba, and H. Kamiya. 1999. Occurrence of myocarditis in rodents infected with Schistosoma mansoni. Southeast Asian J. Trop. Med. Public Health. 30:556-561
9. Chu, V.T., A. Fröhlich, G. Steinhauser, T. Scheel, T. Roch, S. Fillatreau, J.J. Lee, M. Löhning, and C. Berek. 2011. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat. Immunol. 12:151-159. http ://dx .doi .org/10 .1038/ni .1981
10. Chu, V.T., A. Beller, S. Rausch, J. Strandmark, M. Zänker, O. Arbach, A. Kruglov, and C. Berek. 2014. Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis. Immunity. 40:582-593. http ://dx .doi .org/10 .1016/j .immuni .2014 .02 .014
11. Ciháková, D., R.B. Sharma, D. Fairweather, M. Afanasyeva, and N.R. Rose. 2004. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol. Med. 102:175-193
12. Ciháková, D., and N.R. Rose. 2008. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 99:95-114. http ://dx .doi .org/10 .1016/S0065-2776(08)00604-4
13. Ciháková, D., J.G. Barin, M. Afanasyeva, M. Kimura, D. Fairweather, M. Berg, M.V. Talor, G.C. Baldeviano, S. Frisancho, K. Gabrielson, et al. 2008. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am. J. Pathol. 172:1195-1208. http ://dx .doi .org/10 .2353/ajpath .2008 .070207
14. Clark, K., L. Simson, N. Newcombe, A.M.L. Koskinen, J. Mattes, N.A. Lee, J.J. Lee, L.A. Dent, K.I. Matthaei, and P.S. Foster. 2004. Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen. J. Leukoc. Biol. 75:1001-1009. http ://dx .doi .org/10 .1189/jlb .0803391
15. Comarmond, C., C. Pagnoux, M. Khellaf, J.-F. Cordier, M. Hamidou, J.-F. Viallard, F. Maurier, S. Jouneau, B. Bienvenu, X. Puéchal, et al. French Vasculitis Study Group. 2013. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 65:270-281. http ://dx .doi .org/10 .1002/art .37721
16. Cookston, M., M. Stober, and S.G. Kayes. 1990. Eosinophilic myocarditis in CBA/J mice infected with Toxocara canis. Am. J. Pathol. 136:1137-1145
17. Corradi, D., A. Vaglio, R. Maestri, V. Legname, G. Leonardi, G. Bartoloni, and C. Buzio. 2004. Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum. Pathol. 35:1160-1163. http ://dx .doi .org/10 .1016/j .humpath .2004 .05 .008
18. Cugno, M., A.V. Marzano, M. Lorini, V. Carbonelli, and A. Tedeschi. 2014. Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis. PLoS One. 9:e111862. http ://dx .doi .org/10 .1371/journal .pone .0111862
19. Daubeney, P.E.F., A.W. Nugent, P. Chondros, J.B. Carlin, S.D. Colan, M. Cheung, A.M. Davis, C.W. Chow, and R.G. Weintraub. National Australian Childhood Cardiomyopathy Study. 2006. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation. 114:2671-2678. http ://dx .doi .org/10 .1161/CIR CUL ATI ONA HA .106 .635128
20. deMello, D.E., H. Liapis, S. Jureidini, S. Nouri, G.M. Kephart, and G.J. Gleich. 1990. Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N. Engl. J. Med. 323:1542-1545. http ://dx .doi .org/10 .1056/NEJM199011293232207
21. Dimayuga, E., M. Stober, and S.G. Kayes. 1991. Eosinophil peroxidase levels in hearts and lungs of mice infected with Toxocara canis. J. Parasitol. 77:461-466. http ://dx .doi .org/10 .2307/3283136
22. Diny, N.L., X. Hou, J.G. Barin, G. Chen, M.V. Talor, J. Schaub, S.D. Russell, K. Klingel, N.R. Rose, and D. Ciháková. 2016. Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. Eur. J. Immunol. 46:2749-2760. http ://dx .doi .org/10 .1002/eji .201646557
23. Doyle, A.D., E.A. Jacobsen, S.I. Ochkur, L. Willetts, K. Shim, J. Neely, J. Kloeber, W.E. Lesuer, R.S. Pero, P. Lacy, et al. 2013. Homologous recombination into the eosinophil peroxidase locus generates a strain of mice expressing Cre recombinase exclusively in eosinophils. J. Leukoc. Biol. 94:17-24. http ://dx .doi .org/10 .1189/jlb .0213089
24. Felker, G.M., R.E. Thompson, J.M. Hare, R.H. Hruban, D.E. Clemetson, D.L. Howard, K.L. Baughman, and E.K. Kasper. 2000. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 342:1077-1084. http ://dx .doi .org/10 .1056/NEJM200004133421502
25. Fölsch, H., M. Pypaert, P. Schu, and I. Mellman. 2001. Distribution and function of AP-1 clathrin adaptor complexes in polarized epithelial cells. J. Cell Biol. 152:595-606. http ://dx .doi .org/10 .1083/jcb .152 .3 .595
26. Forbes, E., T. Murase, M. Yang, K.I. Matthaei, J.J. Lee, N.A. Lee, P.S. Foster, and S.P. Hogan. 2004. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J. Immunol. 172:5664-5675. http ://dx .doi .org/10 .4049/jimmunol .172 .9 .5664
27. Frustaci, A., M. Caldarulo, A. Buffon, F. Bellocci, R. Fenici, and D. Melina. 1991. Cardiac biopsy in patients with-primary-atrial fibrillation. Histologic evidence of occult myocardial diseases. Chest. 100:303-306. http ://dx .doi .org/10 .1378/chest .100 .2 .303
28. Ginsberg, F., and J.E. Parrillo. 2005. Eosinophilic myocarditis. Heart Fail. Clin. 1:419-429. http ://dx .doi .org/10 .1016/j .hfc .2005 .06 .013
29. Goh, Y.P.S., N.C. Henderson, J.E. Heredia, A. Red Eagle, J.I. Odegaard, N. Lehwald, K.D. Nguyen, D. Sheppard, L. Mukundan, R.M. Locksley, and A. Chawla. 2013. Eosinophils secrete IL-4 to facilitate liver regeneration. Proc. Natl. Acad. Sci. USA. 110:9914-9919. http ://dx .doi .org/10 .1073/pnas .1304046110
30. Gravanis, M.B., G.L. Hertzler, R.H. Franch, L.D. Stacy, A.A. Ansari, K.R. Kanter, H.D. Tazelaar, R. Rodeheffer, and C. McGregor. 1991. Hypersensitivity myocarditis in heart transplant candidates. J. Heart Lung Transplant. 10:688-697
31. Griseri, T., I.C. Arnold, C. Pearson, T. Krausgruber, C. Schiering, F. Franchini, J. Schulthess, B.S. McKenzie, P.R. Crocker, and F. Powrie. 2015. Granulocyte macrophage colony-stimulating factor-activated eosinophils promote interleukin-23 driven chronic colitis. Immunity. 43:187-199. http ://dx .doi .org/10 .1016/j .immuni .2015 .07 .008
32. Guthrie, M., P.A. Lodge, and S.A. Huber. 1984. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2+ cytolytic lymphocytes. Cell. Immunol. 88:558-567. http ://dx .doi .org/10 .1016/0008-8749(84)90188-6
33. Hawkins, E.T., T.B. Levine, S.J. Goss, A. Moosvi, and A.B. Levine. 1995. Hypersensitivity myocarditis in the explanted hearts of transplant recipients. Reappraisal of pathologic criteria and their clinical implications. Pathol. Annu. 30:287-304
34. Heredia, J.E., L. Mukundan, F.M. Chen, A.A. Mueller, R.C. Deo, R.M. Locksley, T.A. Rando, and A. Chawla. 2013. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell. 153:376-388. http ://dx .doi .org/10 .1016/j .cell .2013 .02 .053
35. Herskowitz, A., S. Campbell, J. Deckers, E.K. Kasper, J. Boehmer, D. Hadian, D.A. Neumann, and K.L. Baughman. 1993. Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy. Am. J. Cardiol. 71:982-986. http ://dx .doi .org/10 .1016/0002-9149(93)90918-3
36. Hirasawa, M., Y. Kitaura, H. Deguchi, A. Ukimura, and K. Kawamura. 1998. Spontaneous myocarditis in DBA/2 mice. Light microscopic study with transmission and X-ray analytical electron microscopic studies. Virchows Arch. 432:461-468. http ://dx .doi .org/10 .1007/s004280050192
37. Hirasawa, M., H. Deguchi, A. Ukimura, and Y. Kitaura. 2003. Immunologic interaction between infiltrating eosinophils and T lymphocytes in murine spontaneous eosinophilic myocarditis. Int. Arch. Allergy Immunol. 130:73-81. http ://dx .doi .org/10 .1159/000068371
38. Hirasawa, M., Y. Ito, M.-A. Shibata, and Y. Otsuki. 2007. Mechanism of inflammation in murine eosinophilic myocarditis produced by adoptive transfer with ovalbumin challenge. Int. Arch. Allergy Immunol. 142:28-39. http ://dx .doi .org/10 .1159/000095996
39. Hokibara, S., M. Takamoto, M. Isobe, and K. Sugane. 1998. Effects of monoclonal antibodies to adhesion molecules on eosinophilic myocarditis in Toxocara canis-infected CBA/J mice. Clin. Exp. Immunol. 114:236-244. http ://dx .doi .org/10 .1046/j .1365-2249 .1998 .00661 .x
40. Jacobsen, E.A., K.R. Zellner, D. Colbert, N.A. Lee, and J.J. Lee. 2011. Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation. J. Immunol. 187:6059-6068. http ://dx .doi .org/10 .4049/jimmunol .1102299
41. Jahns, R., V. Boivin, L. Hein, S. Triebel, C.E. Angermann, G. Ertl, and M.J. Lohse. 2004. Direct evidence for α β1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J. Clin. Invest. 113:1419-1429. http ://dx .doi .org/10 .1172/JCI200420149
42. Jung, Y., T. Wen, M.K. Mingler, J.M. Caldwell, Y.H. Wang, D.D. Chaplin, E.H. Lee, M.H. Jang, S.Y. Woo, J.Y. Seoh, et al. 2015. IL-1β in eosinophilmediated small intestinal homeostasis and IgA production. Mucosal Immunol. 8:930-942. http ://dx .doi .org/10 .1038/mi .2014 .123
43. Kasper, E.K., W.R. Agema, G.M. Hutchins, J.W. Deckers, J.M. Hare, and K.L. Baughman. 1994. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J. Am. Coll. Cardiol. 23:586-590. http ://dx .doi .org/10 .1016/0735-1097(94)90740-4
44. Kiwamoto, T., T. Katoh, M. Tiemeyer, and B.S. Bochner. 2013. The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation. Curr. Opin. Allergy Clin. Immunol. 13:106-111. http ://dx .doi .org/10 .1097/ACI .0b013e32835b594a
45. Kopf, M., F. Brombacher, P.D. Hodgkin, A.J. Ramsay, E.A. Milbourne, W.J. Dai, K.S. Ovington, C.A. Behm, G. Köhler, I.G. Young, and K.I. Matthaei. 1996. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 4:15-24. http ://dx .doi .org/10 .1016/S1074-7613(00)80294-0
46. Larsen, B.T., J.J. Maleszewski, W.D. Edwards, L.T. Cooper Jr., R.E. Sobonya, V.E. Thompson, S.G. Duckett, C.R. Peebles, I.A. Simpson, and H.D. Tazelaar. 2013. Atrial giant cell myocarditis: a distinctive clinicopathologic entity. Circulation. 127:39-47. http ://dx .doi .org/10 .1161/CIR CUL ATI ONA HA .112 .128900
47. Lee, N.A., M.P. McGarry, K.A. Larson, M.A. Horton, A.B. Kristensen, and J.J. Lee. 1997. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J. Immunol. 158:1332-1344
48. Leone, O., J.P. Veinot, A. Angelini, U.T. Baandrup, C. Basso, G. Berry, P. Bruneval, M. Burke, J. Butany, F. Calabrese, et al. 2012. 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc. Pathol. 21:245-274. http ://dx .doi .org/10 .1016/j .carpath .2011 .10 .001
49. Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔC T method. Methods. 25:402-408. http ://dx .doi .org/10 .1006/meth .2001 .1262
50. Magnani, J.W., and G.W. Dec. 2006. Myocarditis: current trends in diagnosis and treatment. Circulation. 113:876-890. http ://dx .doi .org/10 .1161/CIR CUL ATI ONA HA .105 .584532
51. Magnani, J.W., H.J.S. Danik, G.W. Dec Jr., and T.G. DiSalvo. 2006. Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am. Heart J. 151:463-470. http ://dx .doi .org/10 .1016/j .ahj .2005 .03 .037
52. Malkiel, S., S. Factor, and B. Diamond. 1999. Autoimmune myocarditis does not require B cells for antigen presentation. J. Immunol. 163:5265-5268
53. Mascaro-Blanco, A., K. Alvarez, X. Yu, J. Lindenfeld, L. Olansky, T. Lyons, D. Duvall, J.S. Heuser, A. Gosmanova, C.J. Rubenstein, et al. 2008. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity. 41:442-453. http ://dx .doi .org/10 .1080/08916930802031579
54. Melo, R.C.N., and P.F. Weller. 2010. Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses. Histol. Histopathol. 25:1341-1354. http ://dx .doi .org/10 .14670/HH-25 .1341
55. Metcalf, D., W.S. Alexander, P.J. Ryan, S. Mifsud, and L. Di Rago. 2001. Production of colony-stimulating factors and IL-5 by organs from three types of mice with inflammatory disease due to loss of the suppressor of cytokine signaling-1. J. Immunol. 167:4661-4667. http ://dx .doi .org/10 .4049/jimmunol .167 .8 .4661
56. Mohrs, M., K. Shinkai, K. Mohrs, and R.M. Locksley. 2001. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity. 15:303-311. http ://dx .doi .org/10 .1016/S1074-7613(01)00186-8
57. Molina, H.A., and F. Kierszenbaum. 1988. Kinetics of development of inflammatory lesions in myocardial and skeletal muscle in experimental Trypanosoma cruzi infection. J. Parasitol. 74:370-374. http ://dx .doi .org/10 .2307/3282040
58. Monteón, V.M., J. Furuzawa-Carballeda, R. Alejandre-Aguilar, A. Aranda-Fraustro, J.L. Rosales-Encina, and P.A. Reyes. 1996. American trypanosomosis: in situ and generalized features of parasitism and inflammation kinetics in a murine model. Exp. Parasitol. 83:267-274. http ://dx .doi .org/10 .1006/expr .1996 .0074
59. Moosig, F., J.P. Bremer, B. Hellmich, J.U. Holle, K. Holl-Ulrich, M. Laudien, C. Matthis, C. Metzler, B. Nölle, G. Richardt, and W.L. Gross. 2013. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann. Rheum. Dis. 72:1011-1017. http ://dx .doi .org/10 .1136/annrheumdis-2012-201531
60. Motomura, Y., H. Morita, K. Moro, S. Nakae, D. Artis, T.A. Endo, Y. Kuroki, O. Ohara, S. Koyasu, and M. Kubo. 2014. Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation. Immunity. 40:758-771. http ://dx .doi .org/10 .1016/j .immuni .2014 .04 .013
61. Nei, Y., K. Obata-Ninomiya, H. Tsutsui, K. Ishiwata, M. Miyasaka, K. Matsumoto, S. Nakae, H. Kanuka, N. Inase, and H. Karasuyama. 2013. GATA-1 regulates the generation and function of basophils. Proc. Natl. Acad. Sci. USA. 110:18620-18625. http ://dx .doi .org/10 .1073/pnas .1311668110
62. Noben-Trauth, N., G. Köhler, K. Bürki, and B. Ledermann. 1996. Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res. 5:487-491. http ://dx .doi .org/10 .1007/BF01980214
63. Ogbogu, P.U., D.R. Rosing, and M.K. Horne III. 2007. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol. Allergy Clin. North Am. 27:457-475. http ://dx .doi .org/10 .1016/j .iac .2007 .07 .001
64. Ong, S., D.L. Ligons, J.G. Barin, L. Wu, M.V. Talor, N. Diny, J.A. Fontes, E. Gebremariam, D.A. Kass, N.R. Rose, and D. Ciháková. 2015. Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration. Am. J. Pathol. 185:847-861. http ://dx .doi .org/10 .1016/j .ajpath .2014 .11 .023
65. Parrillo, J.E., J.S. Borer, W.L. Henry, S.M. Wolff, and A.S. Fauci. 1979. The cardiovascular manifestations of the hypereosinophilic syndrome: Prospective study of 26 patients, with review of the literature. Am. J. Med. 67:572-582. http ://dx .doi .org/10 .1016/0002-9343(79)90227-4
66. Patella, V., G. de Crescenzo, I. Marinò, A. Genovese, M. Adt, G.J. Gleich, and G. Marone. 1996. Eosinophil granule proteins activate human heart mast cells. J. Immunol. 157:1219-1225
67. Pietra, B.A., P.F. Kantor, H.L. Bartlett, C. Chin, C.E. Canter, R.L. Larsen, R.E. Edens, S.D. Colan, J.A. Towbin, S.E. Lipshultz, et al. 2012. Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation. 126:1079-1086. http ://dx .doi .org/10 .1161/CIR CUL ATI ONA HA .110 .011999
68. Pummerer, C.L., K. Luze, G. Grässl, K. Bachmaier, F. Offner, S.K. Burrell, D.M. Lenz, T.J. Zamborelli, J.M. Penninger, and N. Neu. 1996. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J. Clin. Invest. 97:2057-2062. http ://dx .doi .org/10 .1172/JCI118642
69. Qiu, Y., K.D. Nguyen, J.I. Odegaard, X. Cui, X. Tian, R.M. Locksley, R.D. Palmiter, and A. Chawla. 2014. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell. 157:1292-1308. http ://dx .doi .org/10 .1016/j .cell .2014 .03 .066
70. Rose, N.R., K.W. Beisel, A. Herskowitz, N. Neu, L.J. Wolfgram, F.L. Alvarez, M.D. Traystman, and S.W. Craig. 1987. Cardiac myosin and autoimmune myocarditis. Ciba Found. Symp. 129:3-24
71. Rothenberg, M.E., and S.P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24:147-174. http ://dx .doi .org/10 .1146/annurev .immunol .24 .021605 .090720
72. Sagar, S., P.P. Liu, and L.T. Cooper Jr. 2012. Myocarditis. Lancet. 379:738-747. http ://dx .doi .org/10 .1016/S0140-6736(11)60648-X
73. Schultheiss, H.-P., U. Kühl, and L.T. Cooper. 2011. The management of myocarditis. Eur. Heart J. 32:2616-2625. http ://dx .doi .org/10 .1093/eurheartj/ehr165
74. Shamri, R., R.C.N. Melo, K.M. Young, M. Bivas-Benita, J.J. Xenakis, L.A. Spencer, and P.F. Weller. 2012. CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules. FAS EB J. 26:2084-2093. http ://dx .doi .org/10 .1096/fj .11-200246
75. Shirakabe, A., K. Asai, N. Hata, S. Yokoyama, T. Shinada, N. Kobayashi, and K. Mizuno. 2010. Clinical significance of matrix metalloproteinase (MMP)-2 in patients with acute heart failure. Int. Heart J. 51:404-410. http ://dx .doi .org/10 .1536/ihj .51 .404
76. Spencer, L.A., R.C.N. Melo, S.A.C. Perez, S.P. Bafford, A.M. Dvorak, and P.F. Weller. 2006. Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc. Natl. Acad. Sci. USA. 103:3333-3338. http ://dx .doi .org/10 .1073/pnas .0508946103
77. Spry, C.J., P.C. Tai, and J. Davies. 1983. The cardiotoxicity of eosinophils. Postgrad. Med. J. 59:147-153. http ://dx .doi .org/10 .1136/pgmj .59 .689 .147
78. Tai, P.C., D.J. Hayes, J.B. Clark, and C.J. Spry. 1982. Toxic effects of human eosinophil products on isolated rat heart cells in vitro. Biochem. J. 204:75-80. http ://dx .doi .org/10 .1042/bj2040075
79. Takkenberg, J.J.M., L.S.C. Czer, M.C. Fishbein, D.J. Luthringer, A.W. Quartel, J. Mirocha, C.A. Queral, C. Blanche, and A. Trento. 2004. Eosinophilic myocarditis in patients awaiting heart transplantation. Crit. Care Med. 32:714-721. http ://dx .doi .org/10 .1097/01 .CCM .0000114818 .58877 .06
80. Thomas, C.V., M.L. Coker, J.L. Zellner, J.R. Handy, A.J. Crumbley III, and F.G. Spinale. 1998. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation. 97:1708-1715. http ://dx .doi .org/10 .1161/01 .CIR .97 .17 .1708
81. Tian, Z., Y. Zeng, K.-A. Cheng, P. Gao, D.-C. Zhao, Q.-C. Cui, X.-C. Jiang, L.-F. Chen, and Q. Fang. 2010. Importance of endomyocardial biopsy in unexplained cardiomyopathy in China: a report of 53 consecutive patients. Chin. Med. J. (Engl.). 123:864-870
82. Voehringer, D. 2013. Regulation of type 2 immunity by basophils. Adv. Exp. Med. Biol. 785:37-41. http ://dx .doi .org/10 .1007/978-1-4614-6217-0 _4
83. Voehringer, D., N. van Rooijen, and R.M. Locksley. 2007. Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages. J. Leukoc. Biol. 81:1434-1444. http ://dx .doi .org/10 .1189/jlb .1106686
84. Voehringer, D., H.-E. Liang, and R.M. Locksley. 2008. Homeostasis and effector function of lymphopenia-induced-memory-like-T cells in constitutively T cell-depleted mice. J. Immunol. 180:4742-4753. http ://dx .doi .org/10 .4049/jimmunol .180 .7 .4742
85. Voehringer, D., D. Wu, H.-E. Liang, and R.M. Locksley. 2009. Efficient generation of long-distance conditional alleles using recombineering and a dual selection strategy in replicate plates. BMC Biotechnol. 9:69. http ://dx .doi .org/10 .1186/1472-6750-9-69
86. Wang, T.K.M., T. Watson, J. Pemberton, L. Pemberton, B. Lowe, C. Ellis, N. Kingston, and P. Ruygrok. 2016. Eosinophilic myocarditis: characteristics, diagnostics and outcomes of a rare condition. Intern. Med. J. 46:1104-1107. http ://dx .doi .org/10 .1111/imj .13176
87. Weller, P.F., and G.J. Bubley. 1994. The idiopathic hypereosinophilic syndrome. Blood. 83:2759-2779
88. Willebrand, R., and D. Voehringer. 2016. IL-33-induced cytokine secretion and survival of mouse eosinophils is promoted by autocrine GM-CSF. PLoS One. 11:e0163751. http ://dx .doi .org/10 .1371/journal .pone .0163751
89. Wu, D., A.B. Molofsky, H.-E. Liang, R.R. Ricardo-Gonzalez, H.A. Jouihan, J.K. Bando, A. Chawla, and R.M. Locksley. 2011. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science. 332:243-247. http ://dx .doi .org/10 .1126/science .1201475
90. Wu, L., S. Ong, M.V. Talor, J.G. Barin, G.C. Baldeviano, D.A. Kass, D. Bedja, H. Zhang, A. Sheikh, J.B. Margolick, et al. 2014. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J. Exp. Med. 211:1449-1464. http ://dx .doi .org/10 .1084/jem .20132126
91. Xie, M., T.O. Cheng, H. Fei, P. Ren, Y. He, X. Wang, Q. Lu, W. Han, K. Li, L. Li, et al. 2015. The diagnostic value of transthoracic echocardiography for eosinophilic myocarditis: A single center experience from China. Int. J. Cardiol. 201:353-357. http ://dx .doi .org/10 .1016/j .ijcard .2015 .07 .104
92. Yoshida, T., T. Fukuda, M. Hatano, H. Koseki, S. Okabe, K. Ishibashi, S. Kojima, M. Arima, I. Komuro, G. Ishii, et al. 1999. The role of Bcl6 in mature cardiac myocytes. Cardiovasc. Res. 42:670-679. http ://dx .doi .org/10 .1016/S0008-6363(99)00007-3
93. Yu, C., A.B. Cantor, H. Yang, C. Browne, R.A. Wells, Y. Fujiwara, and S.H. Orkin. 2002. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J. Exp. Med. 195:1387-1395. http ://dx .doi .org/10 .1084/jem .20020656
94. Zhang, M., T. Angata, J.Y. Cho, M. Miller, D.H. Broide, and A. Varki. 2007. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood. 109:4280-4287. http ://dx .doi .org/10 .1182/blood-2006-08-039255
95. Zimmermann, N., M.L. McBride, Y. Yamada, S.A. Hudson, C. Jones, K.D. Cromie, P.R. Crocker, M.E. Rothenberg, and B.S. Bochner. 2008. Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy. 63:1156-1163. http ://dx .doi .org/10 .1111/j .1398-9995 .2008 .01709 .x